FindTrial
Sign In

A Study on Developing and Validating a Machine Learning-Based Risk Prediction Model for Postoperative Atrial Fibrillation in Patients with Hypertrophic Obstructive Cardiomyopathy Undergoing Septal Myectomy

Machine Learning-Based Prospective Prediction of Postoperative Atrial Fibrillation Risk in Patients with Hypertrophic Obstructive Cardiomyopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117894
Enrollment
Unknown
Registered
2026-01-29
Start date
2026-01-30
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic Obstructive Cardiomyopathy

Interventions

Observation Group of hypertrophic Obstructive Cardiomyopathy:None

Sponsors

General Hospital of Northern Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of drug-refractory hypertrophic obstructive cardiomyopathy. 2. Scheduled for modified Morrow procedure (septal myectomy). 3. Preoperative cardiac ultrasound examination can be completed. 4. Age >=14 and <=80 years.

Exclusion criteria

Exclusion criteria: 1. Presence of surgical contraindications. 2. Preoperative left ventricular ejection fraction <0.3. 3. Previous history of Morrow surgery. 4. Preoperative persistent atrial fibrillation/flutter or acute myocardial infarction within 7 days. 5. Combined with severe liver, kidney, or lung failure or other diseases with life expectancy <1 year. 6. Requiring concurrent other complex cardiac surgeries.

Design outcomes

Primary

MeasureTime frame
Incidence of Postoperative Atrial Fibrillation (POAF);—

Secondary

MeasureTime frame
Length of ICU stay;Postoperative hospital stay;The actual weight of myocardial resection during operation;Aortic cross-clamp time;A permanent pacemaker was implanted;—

Countries

China

Contacts

Public ContactYin Zongtao

General Hospital of Northern Theater Command

yzt711210@sina.com+86 133 0988 1423

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026